NasdaqCM - Nasdaq Real Time Price USD
Lucid Diagnostics Inc. (LUCD)
At close: November 18 at 4:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,189.0000
2,428.0000
377.0000
500.0000
--
Cost of Revenue
6,411.0000
5,979.0000
3,614.0000
585.0000
--
Gross Profit
-2,222.0000
-3,551.0000
-3,237.0000
-85.0000
--
Operating Expense
42,908.0000
44,931.0000
53,014.0000
27,334.0000
8,280.0000
Operating Income
-45,130.0000
-48,482.0000
-56,251.0000
-27,419.0000
-8,280.0000
Net Non Operating Interest Income Expense
320.0000
8.0000
80.0000
-659.0000
--
Other Income Expense
-8.0000
-4,192.0000
--
--
--
Pretax Income
-44,818.0000
-52,666.0000
-56,171.0000
-28,078.0000
-8,280.0000
Net Income Common Stockholders
-52,314.0000
-52,666.0000
-56,171.0000
-28,078.0000
-8,280.0000
Diluted NI Available to Com Stockholders
-52,314.0000
-52,666.0000
-56,171.0000
-28,078.0000
-8,280.0000
Basic EPS
-1.12
-1.26
-1.55
-1.51
-0.22
Diluted EPS
-1.12
-1.26
-1.55
-1.51
-0.22
Basic Average Shares
46,493.9060
41,756.1290
36,172.4210
18,603.6190
36,992.0770
Diluted Average Shares
46,493.9060
41,756.1290
36,172.4210
18,603.6190
36,992.0770
Total Operating Income as Reported
-45,130.0000
-48,482.0000
-56,251.0000
-27,419.0000
-8,280.0000
Total Expenses
49,319.0000
50,910.0000
56,628.0000
27,919.0000
8,280.0000
Net Income from Continuing & Discontinued Operation
-44,818.0000
-52,666.0000
-56,171.0000
-28,078.0000
-8,280.0000
Normalized Income
-47,790.0000
-52,640.0000
-56,171.0000
-28,078.0000
-8,280.0000
Interest Income
350.0000
424.0000
88.0000
--
--
Interest Expense
30.0000
416.0000
8.0000
659.0000
--
Net Interest Income
320.0000
8.0000
80.0000
-659.0000
--
EBIT
-44,788.0000
-52,250.0000
-56,163.0000
-27,419.0000
-8,280.0000
EBITDA
-43,214.0000
-49,751.0000
-54,227.0000
-27,415.0000
-8,280.0000
Reconciled Cost of Revenue
5,924.0000
5,501.0000
3,327.0000
581.0000
--
Reconciled Depreciation
1,574.0000
2,499.0000
1,936.0000
4.0000
--
Net Income from Continuing Operation Net Minority Interest
-44,818.0000
-52,666.0000
-56,171.0000
-28,078.0000
-8,280.0000
Total Unusual Items Excluding Goodwill
2,972.0000
-26.0000
--
--
--
Total Unusual Items
2,972.0000
-26.0000
--
--
--
Normalized EBITDA
-46,186.0000
-49,725.0000
-54,227.0000
-27,415.0000
-8,280.0000
12/31/2020 - 10/14/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PAVM PAVmed Inc.
1.0200
-10.53%
PAVMZ PAVmed Inc.
0.0275
+82.12%
ALUR Allurion Technologies Inc.
0.3818
+11.31%
VTAK Catheter Precision, Inc.
0.4284
-8.85%
ELUT Elutia Inc.
3.6100
+1.40%
XAIR Beyond Air, Inc.
0.5088
+1.46%
BJDX Bluejay Diagnostics, Inc.
3.7300
+12.69%
APYX Apyx Medical Corporation
1.2300
-2.38%
NPCE NeuroPace, Inc.
8.95
-0.33%
FNA Paragon 28, Inc.
10.20
+1.90%